MA33679B1 - Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole - Google Patents

Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole

Info

Publication number
MA33679B1
MA33679B1 MA34783A MA34783A MA33679B1 MA 33679 B1 MA33679 B1 MA 33679B1 MA 34783 A MA34783 A MA 34783A MA 34783 A MA34783 A MA 34783A MA 33679 B1 MA33679 B1 MA 33679B1
Authority
MA
Morocco
Prior art keywords
oxo
imidazothiadiazole
pyrrolidinyl derivatives
derivatives
pyrrolidinyl
Prior art date
Application number
MA34783A
Other languages
Arabic (ar)
English (en)
Inventor
Yannick Quesnel
Laurent Turet
Joël Mercier
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42034570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33679(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Publication of MA33679B1 publication Critical patent/MA33679B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

L'invention concerne des dérivés de 2-oxo-1-pyrrolidine imidazothiadiazole, leurs procédés de préparation, des compositions pharmaceutiques les contenant et leur utilisation comme produits pharmaceutiques.
MA34783A 2009-10-23 2012-04-19 Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole MA33679B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09173912 2009-10-23
PCT/EP2010/006434 WO2011047860A1 (fr) 2009-10-23 2010-10-21 Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole

Publications (1)

Publication Number Publication Date
MA33679B1 true MA33679B1 (fr) 2012-10-01

Family

ID=42034570

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34783A MA33679B1 (fr) 2009-10-23 2012-04-19 Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole

Country Status (29)

Country Link
US (1) US8822508B2 (fr)
EP (1) EP2491045B1 (fr)
JP (1) JP5808020B2 (fr)
KR (1) KR20120102058A (fr)
CN (1) CN102574869A (fr)
AR (1) AR078722A1 (fr)
AU (1) AU2010310100B2 (fr)
BR (1) BR112012009310B8 (fr)
CA (1) CA2778194C (fr)
CL (1) CL2012001031A1 (fr)
CY (1) CY1117288T1 (fr)
DK (1) DK2491045T3 (fr)
EA (1) EA201200616A1 (fr)
ES (1) ES2565515T3 (fr)
HR (1) HRP20160263T1 (fr)
HU (1) HUE028668T2 (fr)
IL (1) IL218696A0 (fr)
IN (1) IN2012DN02793A (fr)
MA (1) MA33679B1 (fr)
ME (1) ME02355B (fr)
MX (1) MX347070B (fr)
PE (1) PE20121562A1 (fr)
PL (1) PL2491045T3 (fr)
RS (1) RS54595B1 (fr)
SI (1) SI2491045T1 (fr)
SM (1) SMT201600076B (fr)
TN (1) TN2012000147A1 (fr)
TW (1) TW201118103A (fr)
WO (1) WO2011047860A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME02351B (fr) * 2011-04-18 2016-06-20 Ucb Biopharma Sprl Dérivés de 2-oxo-1-imidazolidinyl imidazothiadiazole
US9581654B2 (en) 2013-02-12 2017-02-28 Johnson Controls Technology Company Vehicle battery monitoring system
WO2015110435A1 (fr) 2014-01-21 2015-07-30 Janssen Pharmaceutica Nv Combinaisons comprenant des modulateurs allostériques positifs ou des agonistes orthostériques de sous-type 2 de récepteur glutamatergique métabotrope, et leur utilisation
ME03518B (fr) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Combinaisons comprenant des modulateurs allostériques positifs de sous-type 2 de récepteurs glutamatergiques métabotropes et leur utilisation
WO2019011770A1 (fr) 2017-07-10 2019-01-17 Ucb Biopharma Sprl Dérivés de 2-oxo-1,3-oxazolidinyle imidazothiadiazole
CN110869375B (zh) * 2017-07-10 2022-08-30 Ucb生物制药有限责任公司 2-氧代-1-咪唑烷基咪唑并噻二唑衍生物
CN107827870B (zh) * 2017-10-24 2019-11-08 江苏仁明生物科技有限公司 一种正电子药物[18f]fpmmp及其制备方法与中间体
MA51126A (fr) * 2017-12-12 2020-10-21 UCB Biopharma SRL Dérivés de 2-oxo-1-pyrrolidinyl imidazothiadiazole
ES2947618T3 (es) 2018-05-08 2023-08-14 UCB Biopharma SRL Derivados de 1-imidazotiadiazolo-2H-pirrol-5-ona
CN113549052B (zh) * 2021-07-09 2022-09-02 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 4-苯基-1-（吡啶-4-基甲基）吡咯烷-2-酮衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412357D0 (en) 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412358D0 (en) 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB0004297D0 (en) 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
BRPI0417157A (pt) * 2003-12-02 2007-03-06 Ucb Sa composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
CA2610695A1 (fr) * 2005-06-01 2006-12-07 Ucb Pharma, S.A. Derives de 2-oxo-1-pyrrolidine

Also Published As

Publication number Publication date
IL218696A0 (en) 2012-05-31
CA2778194A1 (fr) 2011-04-28
SMT201600076B (it) 2016-04-29
HUE028668T2 (en) 2016-12-28
US8822508B2 (en) 2014-09-02
US20120245208A1 (en) 2012-09-27
TW201118103A (en) 2011-06-01
IN2012DN02793A (fr) 2015-07-24
HRP20160263T1 (hr) 2016-04-08
CN102574869A (zh) 2012-07-11
JP2013508321A (ja) 2013-03-07
EP2491045A1 (fr) 2012-08-29
CL2012001031A1 (es) 2012-09-14
ME02355B (fr) 2016-06-20
RS54595B1 (en) 2016-08-31
JP5808020B2 (ja) 2015-11-10
BR112012009310B8 (pt) 2021-05-25
AU2010310100A1 (en) 2012-05-17
WO2011047860A1 (fr) 2011-04-28
SI2491045T1 (sl) 2016-04-29
AR078722A1 (es) 2011-11-30
CA2778194C (fr) 2016-07-12
MX2012003839A (es) 2012-05-08
CY1117288T1 (el) 2017-04-26
BR112012009310A2 (pt) 2016-06-07
EA201200616A1 (ru) 2012-12-28
BR112012009310B1 (pt) 2021-01-12
EP2491045B1 (fr) 2015-12-23
PE20121562A1 (es) 2012-11-30
PL2491045T3 (pl) 2016-06-30
TN2012000147A1 (en) 2013-09-19
ES2565515T3 (es) 2016-04-05
DK2491045T3 (en) 2016-03-14
KR20120102058A (ko) 2012-09-17
AU2010310100B2 (en) 2015-09-10
MX347070B (es) 2017-04-11

Similar Documents

Publication Publication Date Title
MA33679B1 (fr) Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole
TN2012000146A1 (fr) Derives de pyrrolo[2,3-d]pyrimidine
MX2015003653A (es) Derivados de amida del acido benzoimidazol-carboxilico como moduladores del receptor apj.
WO2008132139A3 (fr) Nouveaux dérivés hétérocycliques utiles pour le traitement des troubles du système nerveux central
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
CA2883210C (fr) Composes aza bicycliques utilises comme agonistes du recepteur muscarinique m1
WO2008005877A3 (fr) Inhibiteurs de c-kit et leurs utilisations
IN2012DN01233A (fr)
MX2012003555A (es) Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
TW200612892A (en) Novel compounds
MA33492B1 (fr) Inhibiteurs de bace
MX2010009646A (es) Agentes terapeuticos antivirales.
MA30221B1 (fr) Aryldihydro-isoquinoléinones substituées par un azacyclyle, procédé pour leur préparation et leur utilisation en tant que médicaments
EA200801184A1 (ru) Производные пипередин-4-ил-пиридазин-3-иламина как быстро диссоциирующие антагонисты рецептора дофамина 2
TW200738659A (en) Novel compounds
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
MA37742B1 (fr) Dérivés d'oestra-1,3,5 (10), 16-tétraène substitués en position 3, leurs procédés de préparation, préparations pharmaceutiques les contenant, et leur utilisation pour la fabrication de médicaments
MY151005A (en) Amide compounds as boosters of antivirals
GB0611907D0 (en) Compounds
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
ZA200604410B (en) Imidazole derivatives, processes for preparing them and their uses
ATE459600T1 (de) Substituierte pyrrolidin-2-one
MA31863B1 (fr) Dérivés de pyrazole comme inhibiteurs de 5-lo
MX2012001200A (es) (aza)indolizinacarboxamidas ciclicas, su preparacion y su uso como agentes farmaceuticos.